1-20 of 34
Delia Rota Scalabrini
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma

Clinical Trials & Observations Brief Report
Mattia D’Agostino, Giuseppe Bertuglia, Delia Rota-Scalabrini, Angelo Belotti, Sonia Morè, Paolo Corradini, Stefania Oliva, Antonio Ledda, Mariella Grasso, Vincenzo Pavone, Sonia Ronconi, Iolanda Donatella Vincelli, Stelvio Ballanti, Cristina Velluti, Claudia Cellini, Alessandro Gozzetti, Angelo D. Palmas, Barbara Gamberi, Katia Mancuso, Laura Paris, Renato Zambello, Maria Teresa Petrucci, Benedetto Bruno, Pellegrino Musto, Francesca Gay
Journal: Blood
Blood (2024) 143 (7): 592–596.
https://doi.org/10.1182/blood.2023022080
Published: 2024
Includes: Supplemental data
Journal Articles

A Comprehensive and Systematic Analysis of Minimal Residual Disease (MRD) Monitoring in Follicular Lymphoma: Results from the Fondazione Italiana Linfomi (FIL) FOLL12 Trial

Marco Ladetto, Simone Ferrero, Ilaria Del Giudice, Sara Galimberti, Valter Gattei, Luigi Marcheselli, Barbara Mantoan, Elisa Genuardi, Beatrice Alessandria, Martina Ferrante, Irene Dogliotti, Irene Della Starza, Lucia Anna De Novi, Marzia Cavalli, Susanna Grassi, Elena Ciabatti, Francesca Guerrini, Riccardo Bomben, Massimo Degan, Eva Zaina, Tommasina Perrone, Mario Petrini, Francesca Re, Attilio Olivieri, Sara Veronica Usai, Donato Mannina, Brunangelo Falini, Delia Rota Scalabrini, Pietro Maria Stefani, Filippo Ballerini, Massimo Federico, Stefano Luminari
Journal: Blood
Blood (2021) 138 (Supplement 1): 41.
https://doi.org/10.1182/blood-2021-146773
Published: 2021
Journal Articles

Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma

Clinical Trials & Observations
Alessandra Larocca, Francesca Bonello, Gianluca Gaidano, Mattia D’Agostino, Massimo Offidani, Nicola Cascavilla, Andrea Capra, Giulia Benevolo, Patrizia Tosi, Monica Galli, Roberto Marasca, Nicola Giuliani, Annalisa Bernardini, Elisabetta Antonioli, Delia Rota-Scalabrini, Claudia Cellini, Alessandra Pompa, Federico Monaco, Francesca Patriarca, Tommaso Caravita di Toritto, Paolo Corradini, Paola Tacchetti, Mario Boccadoro, Sara Bringhen
Journal: Blood
Blood (2021) 137 (22): 3027–3036.
https://doi.org/10.1182/blood.2020009507
Published: 2021
Includes: Supplemental data
Journal Articles

On-Demand Plerixafor with Cyclophosphamide and G-CSF for Hematopoietic Stem-Cell Mobilization in Multiple Myeloma Patients: Preliminary Results of a Prospective Observational Study (MOZOBL06877)

Roberto Mina, MD, Francesca Bonello, Giuseppe Milone, Maria Teresa Petrucci, Chiara Nozzoli, Velia Bongarzoni, Andrea Capra, Francesco Pisani, Giusy Cetani, Alessandra Malfitano, Delia Rota Scalabrini, Stelvio Ballanti, Roberto M. Lemoli, Patrizia Tosi, Daniele Derudas, Tommaso Caravita di Toritto, Massimo Offidani, Pellegrino Musto, Paolo Corradini, Michele Cavo, Mario Boccadoro, Alessandra Larocca
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–14.
https://doi.org/10.1182/blood-2020-136316
Published: 2020
Journal Articles

Ixazomib-Based Induction Followed By Single-Agent Ixazomib Maintenance in Transplant Ineligible, Newly Diagnosed Multiple Myeloma Patients: Updated Results of the EMN10-Unito Trial

Roberto Mina, MD, Alessandra Larocca, Paolo Corradini, Nicola Cascavilla, Anna Marina Liberati, Norbert Pescosta, Francesca Fazio, Giovannino Ciccone, Andrea Capra, Francesca Patriarca, Annalisa Bernardini, Delia Rota Scalabrini, Michele Cea, Renato Zambello, Anna Baraldi, Angelo Belotti, Mario Boccadoro, Sara Bringhen, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-134671
Published: 2020
Journal Articles

Impact of Imaging FDG-PET/CT Minimal Residual Disease Assessment on Outcomes and Matching with Bone Marrow Techniques in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients: Results of the Phase II Randomized Forte Trial

Elena Zamagni, Cristina Nanni, MD, Francesca Gay, MD, Luca Dozza, MSc, Delia Rota Scalabrini, Mattia D'Agostino, MD, Rossella Ribolla, MD, Monica Galli, Manuela Racca, MD, Renato Zambello, Elena Rivolti, MD, Domenico Albano, MD, Annibale Versari, MD, Mariella Grasso, Rossella Troia, PharmD, Antonio Spadano, Francesca Patriarca, Marina Ruggeri, Marco Rensi, MD, Anna Pascarella, Pietro Zucchetta, MD, Paola Tacchetti, Stefano Fanti, MD PhD, Mario Boccadoro, Michele Cavo, Pellegrino Musto, Stefania Oliva
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-137412
Published: 2020
Journal Articles

Survival Analysis of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients in the Randomized Forte Trial

Francesca Gay, MD, Pellegrino Musto, Delia Rota Scalabrini, Monica Galli, Angelo Belotti, Elena Zamagni, Luca Bertamini, MD, Renato Zambello, Micol Quaresima, Giovanni De Sabbata, Giuseppe Pietrantuono, Mattia D'Agostino, MD, Daniela Oddolo, Andrea Capra, Anna Marina Liberati, Salvatore Palmieri, Franco Narni, Massimo Offidani, Michele Cavo, Mario Boccadoro
Journal: Blood
Blood (2020) 136 (Supplement 1): 35–37.
https://doi.org/10.1182/blood-2020-136907
Published: 2020
Journal Articles

MRD Evaluation By PET/CT According to Deauville Criteria Combined with Multiparameter Flow Cytometry in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients Enrolled in the Phase II Randomized Forte Trial

Elena Zamagni, MD, Cristina Nanni, Francesca Gay, MD, Luca Dozza, MSc, Delia Rota Scalabrini, Paola Omedé, Rossella Ribolla, MD, Monica Galli, Manuela Racca, Renato Zambello, Barbara Gamberi, MD, Domenico Albano, Annibale Versari, Mariella Grasso, Rossella Troia, Tonino Spadano, Francesca Patriarca, Marina Ruggeri, Marco Rensi, Anna Pascarella, Pietro Zucchetta, MD, Paola Tacchetti, Stefano Fanti, Prof, MD PhD, Mario Boccadoro, Michele Cavo, Stefania Oliva
Journal: Blood
Blood (2019) 134 (Supplement_1): 4321.
https://doi.org/10.1182/blood-2019-125134
Published: 2019
Journal Articles

Efficacy and Safety of Ixazomib-Dexamethasone, Ixazomib-Cyclophosphamide-Dexamethasone, Ixazomib-Thalidomide-Dexamethasone and Ixazomib-Bendamustine-Dexamethasone for Elderly Newly Diagnosed Multiple Myeloma (NDMM) Patients: Analysis of the Phase II Randomized Unito-EMN10 Study

Alessandra Larocca, Paolo Corradini, Roberto Mina, Nicola Cascavilla, Anna Marina Liberati, Norbert Pescosta, Maria Teresa Petrucci, Giovannino Ciccone, Andrea Capra, Francesca Patriarca, Delia Rota Scalabrini, Vanessa Innao, Marco Poggiu, Michele Cea, Renato Zambello, Anna Baraldi, Angelo Belotti, Claudia Cellini, Monica Galli, Mariella Grasso, Sara Aquino, Gloria Margiotta Casaluci, Giovanni De Sabbata, Stelvio Ballanti, Massimo Offidani, Katia Mancuso, Mario Boccadoro, Sara Bringhen
Journal: Blood
Blood (2019) 134 (Supplement_1): 3195.
https://doi.org/10.1182/blood-2019-124388
Published: 2019
Journal Articles

Carfilzomib-Lenalidomide-Dexamethasone (KRd) Induction-Autologous Transplant (ASCT)-Krd Consolidation Vs KRd 12 Cycles Vs Carfilzomib-Cyclophosphamide-Dexamethasone (KCd) Induction-ASCT-KCd Consolidation: Analysis of the Randomized Forte Trial in Newly Diagnosed Multiple Myeloma (NDMM)

Francesca Gay, MD, Chiara Cerrato, MD, Delia Rota Scalabrini, MD, Monica Galli, MD, Angelo Belotti, MD, Elena Zamagni, MD, Antonio Ledda, MD, Mariella Grasso, MD, Emanuele Angelucci, MD, Anna Marina Liberati, MD, Patrizia Tosi, MD, Francesco Pisani, MD, Stefano Spada, Ombretta Annibali, MD, Anna Baraldi, MD, Paola Omedé, Piero Galieni, MD, Rita Rizzi, MD, Norbert Pescosta, MD, Sonia Ronconi, MD, Donatella Vincelli, MD, Anna Maria Cafro, MD, Massimo Offidani, MD, Antonio Palumbo, MD, Pellegrino Musto, MD, Michele Cavo, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 121.
https://doi.org/10.1182/blood-2018-99-112093
Published: 2018
Journal Articles

Low Circulating B Lymphocytes in Newly Diagnosed Follicular and Diffuse Large B Cell Lymphoma: Differences Compared to Normal Subjects and Possible Prognostic Role

Riccardo Bruna, Massimo Geuna, Delia Rota Scalabrini, MD, Alessandro Cignetti, MD PhD, Nathalie Santoro, Daniela Gottardi, MD, Roberto Passera, Corrado Tarella, MD Prof
Journal: Blood
Blood (2017) 130 (Supplement 1): 1482.
https://doi.org/10.1182/blood.V130.Suppl_1.1482.1482
Published: 2017
Journal Articles

A Randomized Study of Carfilzomib-Lenalidomide-Dexamethasone Vs Carfilzomib-Cyclophosphamide-Dexamethasone Induction in Newly Diagnosed Myeloma Patients Eligible for Transplant: High Efficacy in High- and Standard-Risk Patients

Francesca Maria Gay, Delia Rota Scalabrini, MD, Angelo Belotti, MD, Monica Galli, MD PhD, Elena Zamagni, MD, Massimo Offidani, MD, Stefania Oliva, MD, Vittorio Montefusco, MD, Renato Zambello, MD, Antonio Ledda, MD, Mariella Grasso, MD, Sara Aquino, MD, Fabrizio Esma, Patrizia Tosi, MD, Francesco Pisani, MD, Ombretta Annibali, Anna Marina Liberati, Anna Baraldi, MD, Piero Galieni, MD, Giorgina Specchia, MD, Norbert Pescosta, MD, Katia Mancuso, MD, Laura Paris, MD, Rossella Ribolla, MD, Valentina Coha, MD, Antonio Palumbo, MD, Pellegrino Musto, MD, Michele Cavo, MD, Mario Boccadoro
Journal: Blood
Blood (2017) 130 (Supplement 1): 4541.
https://doi.org/10.1182/blood.V130.Suppl_1.4541.4541
Published: 2017
Journal Articles

The Combination of Weekly Infusion of Rituximab and Bortezomib Is Effective in Relapsed or Refractory Indolent and Mantle Cell Lymphoma: Long-Term Results of Phase II BRIL06 Study of the Fondazione Italiana Linfomi (FIL)

Annalisa Chiappella, Patrizia Pregno, MD, Pier Luigi Zinzani, Amalia De Renzo, Andrea Evangelista, Alberto Fabbri, Andres J.M. Ferreri, Silvia Franceschetti, Roberto Freilone, Anna Marina Liberati, Maurizio Martelli, Domenico Novero, MD, Lorella Orsucci, MD, Delia Rota-Scalabrini, Luigi Rigacci, Chiara Rusconi, Giorgina Specchia, Vittorio Stefoni, Alessandra Tucci, Francesco Zaja, Umberto Vitolo
Journal: Blood
Blood (2015) 126 (23): 2735.
https://doi.org/10.1182/blood.V126.23.2735.2735
Published: 2015
Journal Articles

Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program

Clinical Trials & Observations
Marco Ladetto, Chiara Lobetti-Bodoni, Barbara Mantoan, Manuela Ceccarelli, Carola Boccomini, Elisa Genuardi, Annalisa Chiappella, Luca Baldini, Giuseppe Rossi, Alessandro Pulsoni, Francesco Di Raimondo, Luigi Rigacci, Antonello Pinto, Sara Galimberti, Alessia Bari, Delia Rota-Scalabrini, Angela Ferrari, Francesco Zaja, Andrea Gallamini, Giorgina Specchia, Pellegrino Musto, Francesca Gaia Rossi, Enrica Gamba, Andrea Evangelista, Umberto Vitolo
Journal: Blood
Blood (2013) 122 (23): 3759–3766.
https://doi.org/10.1182/blood-2013-06-507319
Published: 2013
Includes: Supplemental data
Journal Articles

Prolonged Survival Of Poor Risk Follicular Lymphoma Patients Following Primary Treatment With Rituximab-Supplemented CHOP Or HDS With Autograft: Long-Term Results Of The Multicenter Randomized GITMO/FIL Trial

Corrado Tarella, MD, Fabio Benedetti, MD, Carola Boccomini, MD, Caterina Patti, MD, Anna Maria Barbui, MD, Alessandro Pulsoni, MD, Maurizio Musso, Anna Marina Liberati, Guido Gini, MD, Claudia Castellino, Fausto Rossini, Fabio Ciceri, M.D., Delia Rota Scalabrini, MD, Caterina Stelitano, Francesco Di Raimondo, MD, Tommasina Perrone, Alessandra Tucci, Atto Billio, MD, Francesco Zallio, MD, Valerio Zoli, MD, Angela Congiu, Franco Narni, MD, Alessandra Dondi, Guido Parvis, MD, Gianpietro Semenzato, MD, Paolo Corradini, Riccardo Bruna, MD, Angela Gueli, MD, Barbara Mantoan, Roberto Passera, Michele Magni, MD, Marco Ladetto
Journal: Blood
Blood (2013) 122 (21): 551.
https://doi.org/10.1182/blood.V122.21.551.551
Published: 2013
Journal Articles

Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study

Clinical Trials & Observations
Alessandra Larocca, Vittorio Montefusco, Sara Bringhen, Davide Rossi, Claudia Crippa, Roberto Mina, Monica Galli, Magda Marcatti, Giacinto La Verde, Nicola Giuliani, Valeria Magarotto, Tommasina Guglielmelli, Delia Rota-Scalabrini, Paola Omedé, Alberto Santagostino, Ileana Baldi, Angelo Michele Carella, Mario Boccadoro, Paolo Corradini, Antonio Palumbo
Journal: Blood
Blood (2013) 122 (16): 2799–2806.
https://doi.org/10.1182/blood-2013-03-488676
Published: 2013
Includes: Supplemental data
Journal Articles

Pomalidomide Cyclophosphamide and Prednisone (PCP) Treatment for Relapsed/Refractory Multiple Myeloma

Antonio Palumbo, MD, Alessandra Larocca, MD, Vittorio Montefusco, Davide Rossi, MD, PhD, Angelo Michele Carella, MD, Roberto Mina, MD, Claudia Crippa, MD, Mariella Sciacca, MD, Monica Galli, MD, Delia Rota Scalabrini, MD, Magda Marcatti, MD, Tommasina Guglielmelli, MD, Nicola Giuliani, Giacinto La Verde, MD, Ileana Baldi, MD, Vittorio Emanuele Muccio, Mario Boccadoro, MD, Paolo Corradini, MD
Journal: Blood
Blood (2012) 120 (21): 446.
https://doi.org/10.1182/blood.V120.21.446.446
Published: 2012
Journal Articles

PCR-Based Minimal Residual Disease (MRD) Detection Is a Strong Independent Outcome Predictor Also in Rituximab-Intensive Non-ASCT-Based Programs: Results From the ML17638 Multicenter Randomised Phase III Trial for Elderly Follicular Lymphoma (FL) Patients of the Fondazione Italiana Linfomi (FIL)

Marco Ladetto, MD, Chiara Lobetti-Bodoni, MD, Barbara Mantoan, Ph.D, Andrea Evangelista, Carola Boccomini, MD, Elisa Genuardi, Ph.D, Barbara Botto, Luca Baldini, MD, Giuseppe Rossi, MD, Alessandro Pulsoni, Francesco Di Raimondo, Luigi Rigacci, MD, Antonello Pinto, MD, Mario Petrini, M.D., Ph.D., Stefano Sacchi, Delia Rota-Scalabrini, MD, Luigi Gugliotta, MD, Renato Fanin, MD, Andrea Gallamini, MD, Guido Parvis, MD, Giorgina Specchia, Pellegrino Musto, MD, Barbara Olivero, MD, Enrica Gamba, MD, Giovannino Ciccone, MD, Umberto Vitolo
Journal: Blood
Blood (2012) 120 (21): 787.
https://doi.org/10.1182/blood.V120.21.787.787
Published: 2012
Journal Articles

Prolonged Survival with Low Incidence of CNS Relapse and Late Toxicities in a Retrospective Series of 278 Young Patients with High-Risk (aa-IPI 2–3) Diffuse Large B-Cell Lymphoma Treated with Intensified Chemotherapy with or without Rituximab At Diagnosis

Annalisa Chiappella, Alessia Castellino, Maria Giuseppina Cabras, Anna Marina Liberati, MD, Andrea Evangelista, Chiara Bottelli, Flavia Salvi, Andrea Rossi, Vincenzo Pavone, Maura Nicolosi, Guido Parvis, Anna Tonso, Fausto Rossini, MD, Clara Pecoraro, Delia Rota-Scalabrini, Stefano Luminari, Pasqualina De Masi, Sonia Perticone, Nicola Cascavilla, Roberto Freilone, Umberto Vitolo, MD
Journal: Blood
Blood (2011) 118 (21): 1606.
https://doi.org/10.1182/blood.V118.21.1606.1606
Published: 2011
Journal Articles

A Recent Update of Three Consecutive Prospective Trials with High-Dose Therapy and Autograft, without or with Rituximab, as Primary Treatment for Advanced-Stage Follicular Lymphoma (FL) Shows a Sizeable Group of Patients Surviving in Continuous Complete Remission up to 16 Years After the End of Treatment: Should We Still Consider FL An Incurable Disease ?.

Corrado Tarella, Marco Ladetto, Fabio Benedetti, Umberto Vitolo, Alessandro Pulsoni, Caterina Patti, Vincenzo Callea, Alessandro Rambaldi, Andrea Piccin, Michele Magni, Maurizio Musso, Emilio Iannitto, Pierangelo Spedini, Anna Marina Liberati, Fabio Ciceri, Andrea Gallamini, Francesco Rodeghiero, Guido Gini, Alberto De Crescenzo, Francesco Di Raimondo, Alessandro Levis, Teodoro Chisesi, Tommasina Perrone, Delia Rota Scalabrini, Giuseppe Rossi, Angelo Michele Carella, Guido Parvis, Ignazio Majolino, Roberto Passera, Marco Ruella, Alessandro Pileri, Alessandro Gianni, Paolo Corradini
Journal: Blood
Blood (2009) 114 (22): 882.
https://doi.org/10.1182/blood.V114.22.882.882
Published: 2009